Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An optogenetic-phosphoproteomic study reveals dynamic Akt1 signaling profiles in endothelial cells. | Nat Commun | 2023 | 37365174 | PubTator, text mining | PubMed |
| Inhibition of autophagy; an opportunity for the treatment of cancer resistance. | Front Cell Dev Biol | 2023 | 37363731 | PubTator, text mining | PubMed |
| Destabilized 3'UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models. | Front Genet | 2023 | 37359373 | PubTator, text mining | PubMed |
| The new insights into autophagy in thyroid cancer progression. | J Transl Med | 2023 | 37355631 | PubTator, text mining | PubMed |
| Community detection in empirical kinase networks identifies new potential members of signalling pathways. | PLoS Comput Biol | 2023 | 37352361 | PubTator, text mining | PubMed |
| Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity. | Cancer Res | 2023 | 37339176 | PubTator, text mining | PubMed |
| Hybrid-DIA: intelligent data acquisition integrates targeted and discovery proteomics to analyze phospho-signaling in single spheroids. | Nat Commun | 2023 | 37328457 | PubTator, text mining | PubMed |
| Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets. | Clin Epigenetics | 2023 | 37309005 | PubTator, text mining | PubMed |
| Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies. | Int J Mol Sci | 2023 | 37298431 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia. | Int J Mol Sci | 2023 | 37298150 | PubTator, text mining | PubMed |
| Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance. | Cancers (Basel) | 2023 | 37296966 | PubTator, text mining | PubMed |
| The role of Raptor in lymphocytes differentiation and function. | Front Immunol | 2023 | 37283744 | PubTator, text mining | PubMed |
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study). | Discov Oncol | 2023 | 37278858 | PubTator, text mining | PubMed |
| mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation. | Front Med (Lausanne) | 2023 | 37250653 | PubTator, text mining | PubMed |
| The dichotomous role of immunoproteasome in cancer: Friend or foe? | Acta Pharm Sin B | 2023 | 37250147 | PubTator, text mining | PubMed |
| Insulin signalling and GLUT4 trafficking in insulin resistance. | Biochem Soc Trans | 2023 | 37248992 | PubTator, text mining | PubMed |
| Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit. | Int J Mol Sci | 2023 | 37240345 | PubTator, text mining | PubMed |
| Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart. | Int J Mol Sci | 2023 | 37239977 | PubTator, text mining | PubMed |
| Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System. | Biomolecules | 2023 | 37238686 | PubTator, text mining | PubMed |
| Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14. | Antioxidants (Basel) | 2023 | 37237950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=10